heart failure Archives
Mar. 14, 2013—Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.
Nov. 15, 2012—Under the direction of cardiologist Rebecca Hung, M.D., Vanderbilt Heart and Vascular Institute is offering advanced heart failure services at its Columbia, Tenn., office.
Jan. 5, 2012—Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool: zebrafish. The researchers visually screened...
May. 27, 2011—A new implantable device currently being studied gives heart failure patients the ability to monitor their heart and take action when their condition begins to worsen.